API OTAVA-BB Palbociclib intermediate Cas 571188-59-5

API 99% product OTAVA-BB Palbociclib intermediate Cas: 571188-59-5

Name:  tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate

Other name:OTAVA-BB 1207229

Specification: 99%

CAS NO.: 571188-59-5

EINECS No:695-268-4

Appearance: Yellow powder

Molecular formula:C14H22N4O2

MW: 278.354 
Category:Palbociclib intermediates 

Storage condition: keep in seal, cool and dry place

Shelf time: 2 years

COA: can be requested

Palbociclib (codenamed PD-0332991, trade name Ibrance) is a drug for the treatment of ER-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy by any organization, and as of December 2017 has been prescribed more than 90,000 times.

Our productions of Palbociclib Intermediates:

Picture of Palbociclib Intermediate CAS 571188-59-5

Package & Shipping:

1. Preferentially DHL or FedEx for quantity less than 50KG; Air shipping for 100KG above; Sea shipping for quantity over 500KG.
2. We can offer the complete package from concept to delivery; arranging everything up until products arrive at your own door or distribution hub.
    Delivery can be offered.
  - Utilizing your own freight-forwarder
  - FOB to a port in China
  - CIF to a port near you

Our Service:

1. Supply high quality products with reasonable prices for pharmaceutical factory. 
2. In time delivery, Packing pictures and loading video before loading.
3. Various documents(COA, MSDS, ROS, MOA etc.) and factory audit available. 
4. Pre-sale consultation and post-sale service available.
5. Provide market informations to make customers fully informed.

Company Information:

Shijiazhuang Dingmin Pharmaceutical Sciences Co., Limited is a professional company ocusing on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. We have a R&D center and two plants in Shijiazhuang, Hebei Province. Our Products include active pharmaceutical ingredients (API), pharmaceutical and agrochemical intermediates and chiral compounds. We have won the trust of a wide range of customers/partners in the industry. Our major products are antineoplastic, cardiovascular and antibiotics and their intermediates.
In order to maintain continuous innovation and R & D capability, we maintain long-term and close cooperation with many research institutions and universities, Our co-production plants are located in Anhui, Jiangsu, Zhejiang and Inner Mongolia. The products have been sold to Europe, America, Southeast Asia and other countries and regions
Having upholding the " integrity, profession , innovation, win-win" as business philosophy, we believe that we are able to be stronger and stronger because of the excellent quality, favorable price and full-hearted service. We would like to sincerely welcome friends from all sectors to co-create a brilliant tomorrow together.